middle.news
Rhythm Biosciences Validates ColoSTAT® Test Pathway, Poised for Rapid Scale-Up
8:38am on Wednesday 11th of March, 2026 AEDT
•
Healthcare
Read Story
Rhythm Biosciences Validates ColoSTAT® Test Pathway, Poised for Rapid Scale-Up
8:38am on Wednesday 11th of March, 2026 AEDT
Key Points
First commercial sale of ColoSTAT® colorectal cancer blood test completed
Validated end-to-end clinical and logistical pathway in routine settings
Partnership with 4Cyte Pathology enables sample collection and processing
Immediate scale-up planned via direct physician engagement and ColoSTAT® Access Program
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
RHYTHM BIOSCIENCES (ASX:RHY)
OPEN ARTICLE